血清型A株髄膜炎菌、A群血清型髄膜炎菌、セログループA髄膜炎菌
- 関
- serogroup A meningococcus、serogroup A Neisseria meningitidis
WordNet
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
PrepTutorEJDIC
- answer / ampere
- arsenicの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 髄膜炎菌ワクチン meningococcal vaccines
- 2. 髄膜炎菌の微生物学および病理生物学 microbiology and pathobiology of neisseria meningitidis
- 3. 髄膜炎菌感染の疫学 epidemiology of neisseria meningitidis infection
- 4. 髄膜炎菌感染の診断 diagnosis of meningococcal infection
- 5. 髄膜炎菌感染の臨床症状 clinical manifestations of meningococcal infection
English Journal
- Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies.
- Brodszki N1, Skattum L2, Bai X3, Findlow H3, Borrow R3, Jönsson G4.
- Vaccine.Vaccine.2015 Apr 8;33(15):1839-45. doi: 10.1016/j.vaccine.2015.02.025. Epub 2015 Feb 21.
- Complement C2 deficiency (C2D) is associated with immunological diseases and increased susceptibility to invasive infections caused by encapsulated bacteria such as Neisseria menigitidis. In this study we evaluate the immunogenicity of vaccination against N. menigitidis in C2D. C2D patients (n=22) a
- PMID 25707694
- A Large Portion of Meningococcal Antigen Typing System-Negative Meningococcal Strains from Spain Is Killed by Sera from Adolescents and Infants Immunized with 4CMenB.
- Abad R1, Biolchi A2, Moschioni M2, Giuliani MM2, Pizza M2, Vázquez JA3.
- Clinical and vaccine immunology : CVI.Clin Vaccine Immunol.2015 Apr;22(4):357-60. doi: 10.1128/CVI.00669-14. Epub 2015 Jan 28.
- A new vaccine (the 4CMenB 4-component protein vaccine [Bexsero], which includes PorA, factor H-binding protein [fHbp], neisserial heparin-binding antigen [NHBA], and Neisseria adhesin A [NadA]) against serogroup B meningococci has recently been approved for use in people older than age 2 months in E
- PMID 25630407
- Neisseria meningitidis subverts the polarized organization and intracellular trafficking of host cells to cross the epithelial barrier.
- Barrile R1, Kasendra M, Paccani SR, Merola M, Pizza M, Baldari C, Soriani M, Aricò B.
- Cellular microbiology.Cell Microbiol.2015 Mar 19. doi: 10.1111/cmi.12439. [Epub ahead of print]
- Translocation of the nasopharyngeal barrier by Neisseria meningitidis occurs via an intracellular microtubule-dependent pathway and represents a crucial step in its pathogenesis. Despite this fact, the interaction of invasive meningococci with host subcellular compartments and the resulting impact o
- PMID 25801707
Japanese Journal
- Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry
- PLESTED J. S.
- Infect. Immun. 69, 3203-3213, 2001
- NAID 30020829415
Related Links
- There are currently three vaccines available in the US to prevent meningococcal disease, all quadrivalent in nature, targeting serogroups A, C, W-135 and Y: two conjugate vaccines ...
Related Pictures
★リンクテーブル★
| リンク元 | 「血清型A株髄膜炎菌」「serogroup A Neisseria meningitidis」「A群血清型髄膜炎菌」「セログループA髄膜炎菌」 |
| 関連記事 | 「serogroup」「A」「meningococci」「Ad」 |
「血清型A株髄膜炎菌」
- 英
- serogroup A meningococcus、serogroup A meningococci、serogroup A Neisseria meningitidis
- 関
- セログループA髄膜炎菌、A群血清型髄膜炎菌、A群髄膜炎菌
「serogroup A Neisseria meningitidis」
- 関
- serogroup A meningococci、serogroup A meningococcus
「A群血清型髄膜炎菌」
「セログループA髄膜炎菌」
「serogroup」
「A」